Seneca Therapeutics Company
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.
Technology:
Viral Vectors
Headquarters:
Blue Bell, Pennsylvania, United States
Founded Date:
2018-01-01
Investors Number:
2
Total Funding:
7764372
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-05-04
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership